Scholl Hendrik Peter 4

What Happened
Hendrik P. Scholl, Chief Medical Officer of Belite Bio, sold a total of 10,000 American Depositary Shares (ADSs) in multiple open-market transactions on June 16, 2026, generating approximately $1,405,729 in proceeds. The individual disposals were: 2,054 @ $137.61 ($282,641); 784 @ $138.18 ($108,331); 3,140 @ $139.57 ($438,260); 540 @ $140.58 ($75,915); 100 @ $141.83 ($14,183); 450 @ $142.20 ($63,988); 1,897 @ $143.55 ($272,314); and 1,035 @ $145.02 ($150,097). All transactions are reported as sales (code S).

Key Details

• Transaction date: June 16, 2026; Form 4 filed June 17, 2026 (timely filing).
• Prices ranged roughly from $137.19 to $145.60 (footnotes give weighted-average group ranges for the executed trades).
• Total shares sold: 10,000 ADSs; total proceeds: ~$1.406M.
• Each ADS represents one ordinary share of the issuer (footnote F1).
• Footnotes F2–F8 indicate weighted-average prices and price ranges for grouped sales and offer to provide per-price breakdowns on request.
• The filing does not disclose shares owned by Scholl after these transactions in the summary information provided here.

Context
These were open-market dispositions (sales). Sales by executives can be routine (e.g., diversification or liquidity) but do not by themselves indicate company performance; no purchase, option exercise, gift, or 10b5-1 plan is reported in the provided details.